array:3 [
0 => array:8 [
"idiomaDefecto" => "en"
"pii" => "S2531137925001440"
"gratuito" => false
"doi" => "10.1016/j.htct.2025.103876"
"en" => array:2 [
"titulo" => "VENETOCLAX-BASED VERSUS 7+3 INDUCTION THERAPY IN FIT YOUNGER ADULTS WITH NEWLY DIAGNOSED NON-CBF AML"
"autores" => array:1 [
0 => array:1 [
"autoresLista" => "Dmitrii Zhogolev, Nikita Pastukhov, Bella Aybova, Anna Smirnova, Ivan Moiseev, Sergey Bondarenko, Alexander Kulagin"
]
]
]
"fechaPublicacion" => "01-07-2025"
"highLight" => false
"esBusqueda" => true
]
1 => array:8 [
"idiomaDefecto" => "en"
"pii" => "S2531137921004363"
"gratuito" => false
"doi" => "10.1016/j.htct.2021.10.289"
"en" => array:2 [
"titulo" => "PATTERNS AND PROGNOSTIC IMPACT OF CNS INFILTRATION IN ADULTS WITH NEWLY DIAGNOSED ACUTE LYMPHOBLASTIC LEUKEMIA"
"autores" => array:1 [
0 => array:1 [
"autoresLista" => "LL Perruso, WF Silva, EDRP Velloso, V Rocha, EM Rego"
]
]
]
"fechaPublicacion" => "01-10-2021"
"highLight" => false
"esBusqueda" => true
]
2 => array:8 [
"idiomaDefecto" => "en"
"pii" => "S2531137921004314"
"gratuito" => false
"doi" => "10.1016/j.htct.2021.10.284"
"en" => array:2 [
"titulo" => "MIDOSTAURIN ADDED TO CYTOSINE ARABINOSIDE PLUS IDARUBICIN (“7+3”) IN NEWLY DIAGNOSED FLT3-MUTATED ACUTE MYELOID LEUKEMIA"
"autores" => array:1 [
0 => array:1 [
"autoresLista" => "P Barreto, CE Pizzino, MY Hori, AJU Guimarães, TO Dias, RD Portugal"
]
]
]
"fechaPublicacion" => "01-10-2021"
"highLight" => false
"esBusqueda" => true
]
]
FIVE-YEAR FINAL RESULTS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA (AML)
Outros usuários também visualizaram estes artigos